NM_033305.3:c.3813-171C>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033305.3(VPS13A):c.3813-171C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0575 in 152,118 control chromosomes in the GnomAD database, including 372 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.057 ( 372 hom., cov: 31)
Consequence
VPS13A
NM_033305.3 intron
NM_033305.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.666
Publications
1 publications found
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
VPS13A Gene-Disease associations (from GenCC):
- chorea-acanthocytosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 9-77302744-C-G is Benign according to our data. Variant chr9-77302744-C-G is described in ClinVar as Benign. ClinVar VariationId is 1185291.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.114 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VPS13A | NM_033305.3 | c.3813-171C>G | intron_variant | Intron 33 of 71 | ENST00000360280.8 | NP_150648.2 | ||
| VPS13A | NM_001018037.2 | c.3696-171C>G | intron_variant | Intron 32 of 70 | NP_001018047.1 | |||
| VPS13A | NM_015186.4 | c.3813-171C>G | intron_variant | Intron 33 of 68 | NP_056001.1 | |||
| VPS13A | NM_001018038.3 | c.3813-171C>G | intron_variant | Intron 33 of 68 | NP_001018048.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0575 AC: 8746AN: 152000Hom.: 371 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
8746
AN:
152000
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0575 AC: 8742AN: 152118Hom.: 372 Cov.: 31 AF XY: 0.0566 AC XY: 4211AN XY: 74370 show subpopulations
GnomAD4 genome
AF:
AC:
8742
AN:
152118
Hom.:
Cov.:
31
AF XY:
AC XY:
4211
AN XY:
74370
show subpopulations
African (AFR)
AF:
AC:
638
AN:
41492
American (AMR)
AF:
AC:
708
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
201
AN:
3472
East Asian (EAS)
AF:
AC:
6
AN:
5178
South Asian (SAS)
AF:
AC:
590
AN:
4824
European-Finnish (FIN)
AF:
AC:
603
AN:
10562
Middle Eastern (MID)
AF:
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5803
AN:
67988
Other (OTH)
AF:
AC:
119
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
417
834
1250
1667
2084
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
172
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Chorea-acanthocytosis Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Sep 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.